Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Histamine release via mast cell degranulation is a critical process in the immune system, particularly in allergic and inflammatory responses. Mast cells undergo degranulation upon activation, resulting in the rapid exocytosis of granule contents—including histamine—into the extracellular space. This process involves antigen stimulation, granule translocation, and calcium-dependent granule fusion and exocytosis. Histamine acts through H1R, H2R, H3R, and H4R receptors to mediate various effects, contributing to allergic diseases and inflammatory conditions. Therapeutic strategies focus on inhibiting mast cell degranulation or blocking histamine receptor activity.
Inhibition of mast cell degranulation, Blockage of histamine receptor activity
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Histamine Release (Mast Cell Degranulation).